Delivery Order SPE2DB22D3102-SPE2DB25FL3BH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a $2,010.96 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28S, a hormonal contraceptive medication. This is a firm fixed price, non-set-aside contract with a completion date of September 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $3,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by July 15, 2025, with services provided...
- The Defense Logistics Agency awarded a $4,039.86 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Lo Loestrin Fe 1-10 tablets (quantity: 28-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in a 28-day supply package. This is a firm fixed-price delivery order with a ceiling value of $1,384.70, representing a non-set-aside competitive award. The contract is set to be completed by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,787.85 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages). This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded without set-aside provisions and will...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3BHDelivery Order
The Defense Logistics Agency awarded a $4,912.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. This award falls under AmerisourceBergen's substantial $999.999 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic areas to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive track record of competitively awarded delivery orders demonstrates its capability to fulfill diverse federal medical supply requirements at varying value levels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/16/25 |